About Index Trending news
Analyze
Top 50 Pricing
MyoKardia

MyoKardia

Work at MyoKardia? Add yourself to this profile

MyoKardia

Dedicated to revolutionizing the treatment of genetic heart disease. Focused on cardiomyopathies

Elsewhere

Alexa global traffic share

Twitter followers

Latest funding Show all
Venture capital (Series B)
$46,000,000
Casdin Capital, Cormorant Asset Management, BridgeBio, +2
Venture capital
$10,000,000
Employees

Team size

50+
Xconomy

Despite Sanofi’s Help, MyoKardia Prices IPO Below Expectations

Health Stock markets
Xconomy

Amid Biotech Swoon, Third Rock’s MyoKardia Tees up IPO

Health Funding